TipRanks
pc:racti

Ractigen Therapeutics

Clinical-stage biotechnology company pioneering small activating RNA (saRNA) therapeutics and advanced extrahepatic RNA delivery systems. Focused on developing saRNA candidates for systemic and CNS indications and advancing proprietary delivery platforms to enable extrahepatic targeting.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation―
Estimated Valuation―
Total Amount Raised$31M
Total Amount Raised$31M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$31M
Latest Funding Amount$31M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Jul 29, 2026
Investment
$31.00M
―

Investors

Investor Name
Funding Round

Similar Companies

A snapshot of private companies similar to Ractigen Therapeutics, helping you discover and navigate related company profiles.

Related News and Analysis